Pharma-Bio Serv (PBSV) Market Capitalization (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Market Capitalization for 17 consecutive years, with $11.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 8.57% year-over-year to $11.5 million; the trailing twelve-month figure through Apr 2026 stood at $11.5 million (up 8.57% YoY), and the FY2025 full-year result was $12.4 million, down 7.11% from the prior year.
• Market Capitalization retreated to $11.5 million in Q2 2026 per PBSV's latest filing, from $13.5 million in the prior quarter.
• Across five years, Market Capitalization topped out at $24.6 million in Q3 2023 and bottomed at $10.5 million in Q2 2025.
• Historically, Market Capitalization has averaged $17.5 million across 5 years, with a median of $17.4 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization surged 37.29% in 2023, then plunged 39.27% in 2024.
• Over 5 years, Market Capitalization stood at $19.7 million in 2022, then declined by 1.08% to $19.5 million in 2023, then plunged by 31.78% to $13.3 million in 2024, then fell by 7.11% to $12.4 million in 2025, then declined by 7.42% to $11.5 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $11.5 million, $13.5 million, and $12.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.